Generic Sterile Injectables Market Growing at 10.2% CAGR to US$ 113 Billion By 2025
The process of manufacturing generic sterile injectable is equivalent in the terms of the FDA regulations to that of the branded counterparts.
Content
The process of manufacturing generic sterile injectable is equivalent in the terms of the FDA regulations to that of the branded counterparts.
